BackEsperion Therapeutics Overview
Esperion Therapeutics Inc.

Esperion Therapeutics PEG Ratio

Esperion Therapeutics (ESPR) has a PEG ratio of 348.38, above the Healthcare sector average of 11.64.

Get informed when a big investor buys or sells

+ Follow

PEG Ratio

348.38

PEG Ratio

348.38

The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.

Average PEG Ratio (Comparison Companies)

Loading

PEG Ratio History

Loading

PEG Ratio Comparison

Loading

Esperion Therapeutics (ESPR) FAQ

As of the most recent data, ESPR shows a PEG ratio of 348.38. That is above the Healthcare sector average of 11.64. Scroll down for historical charts and peer comparison views.

The Healthcare sector average PEG ratio is about 11.64. Esperion Therapeutics is at 348.38, which is higher that average. That is roughly 2892.8% above the sector mean. Use the comparison chart on this page to see how ESPR stacks up against individual peers as well.

Investors watch ESPR's PEG ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Esperion Therapeutics's latest reading is 348.38. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.

Besides this peg ratio page, Stockcircle has Esperion Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect PEG ratio (currently 348.38) with ownership activity and broader fundamentals.

The Healthcare average PEG ratio is about 11.64, while ESPR is at 348.38. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.